INFQ
New analyst love, same old quantum chaos
Infleqtion got a little love note from Wall Street on Thursday, and the stock liked it. Canaccord Genuity kicked off coverage with a Buy rating and a $22 price target, implying roughly 70% upside from current levels.
That’s not nothing for a company that only started trading in February. When a stock is still trying to build its own investor crowd, new analyst coverage can feel a bit like the first loud person at a party: suddenly everybody turns around.
Why the market cared
Wedbush had already made the bull case last week, calling Infleqtion “meaningfully mispriced” and slapping on an Outperform rating with a $20 target. So this wasn’t a total surprise — more like another vote in the “maybe the market is underestimating this thing” column.
A few ingredients are doing the heavy lifting here:
- Limited coverage since the stock’s February debut
- Ongoing skepticism around neutral-atom quantum tech
- A new policy tailwind after the June 22 White House order pushing federal agencies to speed up quantum development
The quantum pitch in plain English
Infleqtion isn’t just trying to be the cool quantum computing kid. It’s building a full-stack platform across quantum sensing, computing, and software, with customers and use cases ranging from defense to energy to cybersecurity.
The bullish crowd thinks investors may be treating it like mostly a sensing story, while underestimating the longer-term computing angle. And to make the plot a little more interesting, the company is also linked to $100 million in Department of Commerce funding for large-scale neutral-atom quantum computing systems.
Big picture
This is still a small, high-voltage stock in a market that can go from euphoric to side-eye in a heartbeat. But when analyst coverage stacks up and Washington starts throwing elbows behind quantum tech, you get the kind of setup that can keep traders interested — even if the broader tech sector is having a meh day.